Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of SARS-CoV-2 Infection on the Incidence of ICU Acquired Colonization Related to Multidrug-resistant Bacteria

NCT04378842 is registered in ClinicalTrials.gov with University Hospital, Lille as lead sponsor.

NCT NCT04378842
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04378842 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of SARS-CoV-2 Infection on the Incidence of ICU Acquired Colonization Related to Multidrug-resistant Bacteria
Lead sponsor
University Hospital, Lille
Phase
Observational
Overall status
Completed
Start date
May 18, 2020
Completion date
July 26, 2021
Enrollment
368 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

critical illness, sars-cov2